z-logo
Premium
Regulation of β‐nerve growth factor expression by inflammatory mediators in hippocampal cultures
Author(s) -
Friedman W. J.,
Lärkfors L.,
AyerLeLievre C.,
Ebendal T.,
Olson L.,
Persson H.
Publication year - 1990
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.490270316
Subject(s) - nerve growth factor , hippocampal formation , endocrinology , medicine , activator (genetics) , lipopolysaccharide , biology , messenger rna , in vitro , chemistry , microbiology and biotechnology , biochemistry , receptor , gene
Substances which regulate expression of nerve growth factor (NGF) were examined in embryonic rat: hippocampal cultures containing both neurons and glial cells. Both cell types expressed NGF mRNA when cultivated in vitro. Lipopolysaccharide, an activator of macrophages, elicited a significant increase in NGF mRNA. Interleukin‐1β evoked a similar increase in NGF mRNA which was accompanied by a rise in NGF protein. The II‐1‐induced increase was partially blocked by indomethacin, suggesting that prostaglandins might mediate this effect. Treatment of the cultures directly with prostaglandin E 2 resulted in elevated levels of both NGF mRNA and protein. Thus, agents which promote inflammatory activity appear to increase NGF expression. Moreover, a suppressor of inflammation, dexamethasone, decreased NGF expression. Our observations indicate that a variety of immunomodulators regulate NGF expression in the hippocampus.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom